Coenzyme Q10 alleviates tacrolimus-induced mitochondrial dysfunction in kidney.
Ontology highlight
ABSTRACT: The major side effect of tacrolimus (Tac) is nephrotoxicity. We studied whether supplementation of coenzyme Q10, (CoQ10) a potent antioxidant, can reduce Tac-induced nephrotoxicity via improving mitochondrial function. In an in vitro study, CoQ10 reduced the production of Tac-induced mitochondrial reactive oxygen species and abolished the loss of mitochondrial membrane potential in proximal tubular cell line. Assessment of mitochondrial function revealed that CoQ10 decreased oxygen consumption and mitochondrial respiration rate increased by Tac, suggesting improvement of mitochondrial function to synthesize ATP with CoQ10 treatment. The effect of the CoQ10 in vitro study was observed in an experimental m
SUBMITTER: Yu JH
PROVIDER: S-EPMC6902707 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA